A methodology is presented for following a cohort of older depressed patients to examine neurocognitive outcomes of depression. A total of 265 depressed individuals and 138 healthy, nondepressed controls age 60 and older who completed at least 1 year of follow-up data underwent periodic clinical evaluation by a geriatric psychiatrist. A subset of 141 patients and 137 controls had neuropsychological testing. A consensus panel of experts reviewed 63 depressed subjects with suspected cognitive impairment. Twenty-seven individuals in the depressed group were assigned diagnoses of dementia, including 11 with Alzheimer’s disease, 8 with vascular dementia, and 8 with dementia of undetermined etiology. In addition, 25 individuals had other forms of cognitive impairment, and 11 were considered cognitively normal. Among elderly controls, 2 developed substantial cognitive impairment with clinical diagnoses of dementia. Among the depressed group, the incidence rates for dementia for this age are much higher than would be expected. These results are consistent with prior evidence linking depression and later dementia. Future studies are needed to examine neuroimaging and genetic, clinical, and social predictors of neurocognitive decline in depression.
1. Steffens DC, Plassman BL, Helms MJ, et al. A twin study of lateonset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer’s disease. Biol Psychiatry. 1997;41:851-856.
2.
2. Devanand DP, Sano M, Tang MX, et al. Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry. 1996;53:175-182.
3.
3. Steffens DC, MacFall JR, Payne ME, et al. Grey-matter lesions and dementia. Lancet. 2000;356:1686-1687.
4.
4. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry. 2001;35:776-781.
5.
5. Jellinger KA, Bancher C.Neuropathology of Alzheimer’s disease: a critical update. J Neural Transm Suppl. 1998;54:77-95.
6.
6. Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002;58:750-775.
7.
7. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998;29:388-398.
8.
8. Snowdon DA, Greiner LH, Markesbery WR. Linguistic ability in early life and the neuropathology of Alzheimer’s disease and cerebrovascular disease: findings from the Nun Study. Ann N Y Acad Sci. 2000;903:34-38.
9.
9. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43:1467-1472.
10.
10. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
11.
11. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921-923.
12.
12. Hamilton M.A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:55-61.
13.
13. Montgomery SA, Asberg M.A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
14.
14. Landerman R, George LK, Campbell RT, Blazer DG. Alternative models of the stress buffering hypothesis. Am J Comm Psychol. 1989;17:626-642.
15.
15. Robins N, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health diagnostic interview schedule. Arch Gen Psychiatry. 1981;38:381-389.
16.
16. Hays JC, Steffens DC, Flint EP, et al. Does social support buffer functional decline in elderly patients with unipolar depression?Am J Psychiatry. 2001;158:1850-1855.
17.
17. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
18.
18. Steffens DC, McQuoid DR, Krishnan KRR. The Duke somatic treatment algorithm for geriatric depression (STAGED) approach. Psychopharmacol Bull. 2002;36:58-68.
19.
19. Steffens DC, Byrum CE, McQuoid DR, et al. Hippocampal volume in geriatric depression. Biol Psychiatry. 2000;48:301-309.
20.
20. Payne ME, Fetzer DL, MacFall JR, et al. Development of a semiautomated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res. 2002;115:63-77.
21.
21. Tschanz JT, Welsh-Bohmer KA, Skoog I, et al. Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology. 2000;54:1290-1296.
22.
22. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I: clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39:1159-1165.
23.
23. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry of Alzheimer’s Disease (CERAD). Part V: a normative study of the neuropsychological battery. Neurology. 1994;44:609-614.
27. Benton AL, Hamsher K, Varney N, Spreen O.Contributions to Neuropsychological Assessment. New York, NY: Oxford University Press; 1983.
28.
28. Reitan RM. Trail Making Test: Manual for Administration and Scoring. Tucson,Ariz: Reitan Neuropsychological Laboratory; 1992.
29.
29. Smith A.Symbol Digit Modalities Test-Manual. Los Angeles, Calif: Western Psychological Services; 1982.
30.
30. Wechsler D.The Wechsler Adult Intelligence Scale Revised. New York, NY: Psychological Corporation; 1981.
31.
31. Hoppe CD, Muller UD, Werheid KD, et al. Digit Ordering Test: clinical, psychometric, and experimental evaluation of a verbal working memory test. Clin Neuropsychol. 2000;14:38-55.
32.
32. Zachary RA. Shipley Institute of Living Scale–Revised Manual. Los Angeles, Calif: Western Psychological Services; 1991.
33.
33. Clark CM, Ewbank DC. Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Disord. 1996;10:31-39.
34.
34. Breitner JCS, Welsh KA, Robinette CD, et al. Alzheimer’s disease in the National Academy of Sciences Registry of aging twin veterans: II. Longitudinal findings in a pilot series. Dementia. 1994;5:99-105.
35.
35. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer’s disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans: III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol. 1995;52:763-771.
36.
36. Breitner JC, Wyse BW, Anthony JC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999;53:321-331.
37.
37. Welsh KA, Butters N, Hughes JP, et al. Detection and staging of dementia in Alzheimer’s disease. Arch Neurol. 1992;49:448-452.
38.
38. Robinson-Whelen S, Storandt M.Immediate and delayed prose recall among normal and demented adults. Arch Neurol. 1992;49:32-34.
39.
39. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type: II. Psychometric test performance. Arch Neurol. 1989;46:383-386.
40.
40. Welsh K, Butters N, Hughes J, et al. Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol. 1991;48:278-281.
41.
41. Lezak MD, ed. The neuropsychological examination: interpretation. In: Neuropsychological Assessment. New York, NY: Oxford University Press; 1995:144-169.
42.
42. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task force on Alzheimer’s disease. Neurology. 1984;34:939-944.
43.
43. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology. 1993;43:250-260.
44.
44. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
45.
45. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793-1796.
46.
46. Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59:1737-1746.
47.
47. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003;60:185-189.
48.
48. Jorm AF, van Duijn CM, Chandra V, et al. Psychiatric history and related exposures as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20(suppl 2):S43-S47.
49.
49. Kokmen E, Beard CM, Chandra V, et al. Clinical risk factors for Alzheimer’s disease: a population-based case-control study. Neurology. 1991;41:1393-1397.
50.
50. van Duijn CM, Clayton DG, Chandra V, et al. Interaction between genetic and environmental risk factors for Alzheimer’s disease: a reanalysis of case-control studies. Genet Epidemiol. 1994;11:539-551.
51.
51. Speck CE, Kukull WA, Brenner DE, et al. History of depression as a risk factor for Alzheimer’s disease. Epidemiology. 1995;6:366-369.
52.
52. Green RC, Cupples LA, Kurz A, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60:753-759.
53.
53. Wilson RS, Mendes de Leon CF, Bennett DA, et al. Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry. 2004;75:126-129.
54.
54. Alexopoulos GS, Meyers BS, Young RC, et al. “Vascular depression” hypothesis. Arch Gen Psychiatry. 1997;54:915-922.
55.
55. Steffens DC, Krishnan KRR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998;43:705-712.
56.
56. Nebes RD, Butters MA, Mulsant BH, et al. Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychol Med. 2000;30:679-691.
57.
57. Alexopoulos G, Young R, Meyers B.Geriatric depression: age of onset and dementia. Biol Psychiatry. 1993;34:141-145.
58.
58. Alexopoulos GS, Meyers BS, Young RC, et al. The course of geriatric depression with “reversible dementia”: a controlled study. Am J Psychiatry. 1993;150:1693-1699.
59.
59. Kral VA, Emery OB. Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry. 1989;34:445-446.
60.
60. Reding M, Haycox J, Blass J.Depression in patients referred to a dementia clinic: a three year prospective study. Arch Neurol. 1985;42:894-896.
61.
61. Chen P, Ganguli M, Mulsant B, et al. The temporal relationship between depressive symptoms and dementia: a communitybased prospective study. Arch Gen Psychiatry. 1999;56:261-266.
62.
62. McFarland C, Sweet RA, DeKosky ST, et al. The establishment of a brain bank for the study of late-life depression: a feasibility study of factors facilitating consent. CNS Spectr. 2000;7:816-821.
63.
63. Thomas AJ, Perry R, Barber R, et al. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci. 2002;977:333-339.
64.
64. Plassman BL, Havlik RJ, Steffens DC, et al. Documented head injury in early adulthood increases risk of Alzheimer’s disease and other dementias 50 years later. Neurology. 2000;55:1158-1166.
